Pharmacological management of PCOS: trends and insights from a 10-year bibliometric analysis.

BACKGROUND

PCOS is an endocrine disorder affecting women of reproductive-aged group. It has multiple manifestations, including metabolic, reproductive, and psychological domains. Among PCOS patients, pharmaceutical management remains a primary approach to its treatment, particularly when lifestyle changes do not yield improvements.

OBJECTIVE

This study aims to highlight trends in global research concerning PCOS and its pharmacological treatment within the last decade using bibliometric analysis.

METHODS

A bibliometric analysis was conducted for the 2015-2024 timeframe using Web of Science database. Search queries were designed for PCOS as well as its pharmacological treatment options. Data analysis was performed through visualization of collaborations, research trends, etc. in VOS viewer.

RESULTS

2607 publications qualified for inclusion criteria. The most frequently treated topics were combined oral contraceptives, metformin, letrozole, and inositols. China is the leading contributor toward publication volume, while the U.S.A. was the most cited and had the strongest links. Influence appeared to stem from Monash University, and Legro RS was the most influential the most impactful author.

CONCLUSION

The study reveals global trends in PCOS pharmacotherapy, with a growing focus on metabolic and molecular aspects. Key contributors and emerging therapies highlight the expanding scope and future potential of PCOS treatment research.